FDA approves vimseltinib for tenosynovial giant cell tumor and a triplet for R/R LBCL, plus the latest from ASCO GU 2025.

In the Philippines, access to comprehensive genomic profiling (CGP), circulating tumor DNA (ctDNA), and cell-free DNA (cfDNA) ...

Doctors at Lakeland Regional Health are now equipped with cutting-edge robotic technology to better detect lung cancer.

Biomarker testing has the potential to improve patient outcomes significantly, but its high cost means it's not accessible to everyone.

Experts say there are reasons why people in some parts of the country are more likely to die from cancer, and they can be avoided ...

Cancer treatment has advanced significantly, helping more people live longer, healthier lives. However, some of these life ...

Research by Cancer Research UK found that about 28,400 cancer deaths each year are associated with deprivation.

Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing ...

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

The tool predicts which of two standard front-line chemotherapy options a patient with advanced pancreatic cancer is likely to benefit from.

In a Phase Ib trial, 71 percent of patients responded to zongertinib and lived a median six months before disease progression or death.

Nowadays, targeted therapies remain the gold standard for many patients ... The results of the phase I trial conducted on advanced or metastatic non-small cell lung cancer (NSCLC) patients bearing ...